XENT Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (1 jan 1970 @ 01:00):

Stats
Dagens volum	0.00
Gjennomsnittsvolum	438 704
Markedsverdi	0.00
EPS	$-0.850 ( 2022-05-04 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-10.54
ATR14	$0.137 (0.49%)

Insider Trading

Date	Person	Action	Amount	type
2022-05-13	Meier Richard A	Sell	57 230	Common Stock
2022-05-13	Meier Richard A	Sell	65 759	Common Stock
2022-05-13	Meier Richard A	Sell	40 607	Common Stock
2022-05-13	Meier Richard A	Sell	34 000	Stock Options (Right to buy)
2022-05-13	Meier Richard A	Sell	74 852	Stock Options (Right to buy)

INSIDER POWER
-100.00
Last 98 transactions
Buy: 482 629 \| Sell: 874 745

Volum Korrelasjon

Lang: 0.54 (weak)

Kort: 0.61 (weak)

Signal:(64.961) Neutral

Intersect Ent Inc Korrelasjon

10 Mest positive korrelasjoner
GLLI	0.937
ACAB	0.933
FEXD	0.929
APMI	0.929
FNVT	0.929
AVAC	0.928
CBRG	0.926
CIIG	0.925
BRIV	0.923
ALSA	0.921

10 Mest negative korrelasjoner
EVLO	-0.925
NCBS	-0.923
IRBT	-0.922
CREG	-0.92
DRUG	-0.917
ATAI	-0.916
CRON	-0.913
ARQQ	-0.912
BLU	-0.911
VFF	-0.91

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Intersect Ent Inc Korrelasjon - Valuta/Råvare

0.00
( neutral )

0.63
( weak )

0.00
( neutral )

0.21
( neutral )

0.07
( neutral )

0.05
( neutral )

Intersect Ent Inc Økonomi

Annual	2021
Omsetning:	$106.75M
Bruttogevinst:	$76.74M (71.89 %)
EPS:	$-4.80

FY	2021
Omsetning:	$106.75M
Bruttogevinst:	$76.74M (71.89 %)
EPS:	$-4.80

FY	2020
Omsetning:	$80.55M
Bruttogevinst:	$50.25M (62.38 %)
EPS:	$-2.22

FY	2019
Omsetning:	$109.14M
Bruttogevinst:	$87.37M (80.05 %)
EPS:	$-1.370

Financial Reports:

No articles found.

Intersect Ent Inc

Intersect ENT, Inc. operates as an ear, nose, and throat (ENT) medical technology company in the United States. The company offers PROPEL, a steroid releasing implant to open the surgically enlarged sinus; PROPEL Mini, a releasing implant to treat patients undergoing frontal sinus surgery; and PROPEL Contour, a steroid releasing implant for the treatment of frontal and maxillary sinus ostia, or openings, of the dependent sinuses. It also provides SINUVA, a steroid releasing implant for the treatment of patients in the physician office setting; VENSURE Navigable and Stand-alone balloon, a sterile and single-use device, used to access and treat frontal, sphenoid sinus, and maxillary ostia in adults using a trans-nasal approach; and CUBE Navigation System, a virtual guidance platform for high precision ENT and ENT related skull-base surgeries. The company was formerly known as Sinexus, Inc. and changed its name to Intersect ENT, Inc. in November 2009. Intersect ENT, Inc. was incorporated in 2003 and is headquartered in Menlo Park, California.